CJC 1295 DAC 5 mg Peptide (Research Grade)

Long-Acting Growth Hormone Releasing Peptide for Advanced Research

CJC 1295 DAC 5 mg is a long-acting research peptide widely studied for its ability to stimulate sustained growth hormone release through growth hormone–releasing hormone (GHRH) pathways. The addition of DAC (Drug Affinity Complex) significantly extends the peptide’s half-life, allowing prolonged activity and reduced dosing frequency in research models. This makes CJC 1295 DAC an ideal compound for laboratories focusing on growth hormone regulation, metabolic balance, muscle recovery, and regenerative research. This product is supplied as a high-purity lyophilized powder and is intended for research use only and not for human consumption.

Benefits & Features

Benefits

• Supports sustained growth hormone release in research settings

• Enables long-acting metabolic and regenerative pathway studies

• Reduces dosing frequency due to extended peptide stability

• Ideal for long-term experimental protocols

Features

• Precisely dosed 5 mg peptide content

• Research-grade purity (≥99%)

• Lyophilized powder for maximum stability and shelf life

• Manufactured under sterile, quality-controlled laboratory conditions

Who It’s Best For

• Growth hormone and metabolic research laboratories

• Scientists studying muscle recovery and tissue regeneration

• Researchers requiring extended-release peptide compounds

• Advanced peptide research institutions

Specifications

• Product Name: CJC 1295 DAC

• Strength: 5 mg

• Form: Lyophilized powder

• Purity: ≥99%

• Use: Research use only

• Storage: Store in a cool, dry place; refrigerate after reconstitution

Performance (Distance, Forgiveness, Feel)

• Distance: Prolonged molecular interaction with GHRH receptors

• Forgiveness: DAC binding enhances stability and minimizes degradation

• Feel: Smooth solubility and consistent preparation performance